Acetylcholine: Synthesis, Function, and Receptors in Biochemistry

Acetylcholine: Structure, Synthesis, and Function

Definition and Functions of Acetylcholine (ACh)

Acetylcholine is a major neurotransmitter in both the central and peripheral nervous systems. It plays a crucial role in transmitting nerve impulses across synapses and neuromuscular junctions.

• Neurotransmitter: Chemical messenger facilitating communication between neurons and muscles.

• Functions:

  • Neuromuscular junction signaling (muscle contraction)

  • Learning and memory processes

  • Nicotine addiction

  • Sympathetic and parasympathetic nervous system activity

  • Interneuron signaling

Precursors and Sources of Acetylcholine

Acetylcholine is synthesized from several key precursors, each obtained from different sources:

• Acetyl CoA: Produced in the Krebs cycle (mitochondria)

• Choline: Obtained from dietary intake and endogenous synthesis

• Coenzyme A: Generated in mitochondria

Synthesis of Acetylcholine

The synthesis of acetylcholine involves a single enzymatic step:

• Choline is transported into the neuron by a bidirectional choline transporter across the blood-brain barrier.

• Enzymatic Reaction: Choline + Acetyl CoA → Acetylcholine + Coenzyme A (catalyzed by choline acetyltransferase)

$\text{Choline} + \text{Acetyl CoA} \xrightarrow{\text{choline acetyltransferase}} \text{Acetylcholine} + \text{Coenzyme A}$

• Choline acetyltransferase is synthesized in the endoplasmic reticulum and transported to axon terminals.

• Exists freely in the cytoplasm and catalyzes the reversible transfer of the acetyl group.

Regulation: The rate of ACh synthesis is controlled by the availability of precursors and the rate of neuronal firing. Large doses of choline may be used therapeutically (e.g., in Alzheimer's disease).

Distribution and Selectivity

• Cholinergic neurons are selectively marked by choline acetyltransferase.

• Ch1 and Ch2 neurons innervate the hippocampal complex; Ch3 the olfactory bulb; Ch4 the cerebral cortex and amygdala.

• Ch4-neurons are located in the nucleus basalis of Meynert (NBM).

Storage, Release, and Inhibition of Acetylcholine

Vesicular Storage and Release

• Vesicular Acetylcholine Transporter (VAChT): Transports ACh from the cytoplasm into synaptic vesicles.

• Vesamicol: Drug that blocks VAChT, preventing ACh storage and release, leading to paralysis.

• Quantal Release: ACh is released in discrete packets (quanta) upon nerve stimulation.

• α-latrotoxin (black widow spider venom): Acts as an ionophore for Ca2+, causing massive exocytosis and neurotransmitter release.

Inhibitors of Choline Uptake

• Hemicholinium-3 (HC-3): Inhibits high-affinity choline uptake (does not cross the blood-brain barrier).

• Triethylcholine (TEC): Also inhibits choline uptake.

Acetylcholinesterase (AChE)

Acetylcholinesterase is the enzyme responsible for the breakdown of acetylcholine into choline and acetate, terminating synaptic transmission.

• Highly concentrated in the brain and neuromuscular junctions.

• Attached to the membrane of the postsynaptic cell as a glycoprotein.

Drugs Affecting Acetylcholinesterase

Several drugs can inhibit or modulate the activity of acetylcholinesterase, with therapeutic and toxicological implications.

Drug	Effect
Physostigmine	Reversible inhibitor that crosses the BBB; lethal toxin that blocks AChE
Neostigmine/Pyridostigmine	Reversible inhibitors; do not cross the BBB; beneficial for myasthenia gravis (autoimmune disorder)
Nerve gas	Irreversible inhibitor; overstimulates muscles, glands, and other tissues; can cause death by blocking AChE

Anticholinesterases

• Cholinergic stimulants that inactivate acetylcholinesterase (AChE), increasing ACh levels.

• Enhance the action of endogenous ACh at both nicotinic and muscarinic receptors.

Clinical Relevance: Myasthenia Gravis

• Autoimmune disease where antibodies block ACh binding sites on receptors.

• Results in fewer functional receptors, decreased nerve impulse transmission, and muscle weakness.

Stress and Pyridostigmine Potency

• Pyridostigmine is used as a nerve gas antidote.

• Stress increases blood-brain barrier permeability, enhancing protection of AChE from permanent inactivation.

Cholinergic Pathways and Pharmacology

Cholinergic Pathways in the Brain

• Caudate putamen: abundant cholinergic interneurons

• Basal forebrain: projects axons to cortex

• Nucleus basalis/substantia innominata, medial septum, laterodorsal and pedunculopontine tegmental nuclei: sources of cholinergic cell bodies projecting to various brain regions

• Pendunculopontine tegmental nuclei: project to pons, cerebellum, and spinal cord

Pharmacological Management in Parkinson's Disease

• Anticholinergic drugs are prescribed to regulate ACh action in cholinergic interneurons as dopamine levels decrease in early-stage Parkinson's disease.

Role of Acetylcholine in the Autonomic Nervous System (ANS)

• ACh is crucial in both sympathetic and parasympathetic branches.

• Acts at both preganglionic and postganglionic neurons.

Cholinergic Receptors: Nicotinic and Muscarinic

Nicotinic vs. Muscarinic Receptors

• Nicotinic receptors:

  • Ionotropic (ligand-gated ion channels)

  • Respond to nicotine; found in substantia nigra, locus coeruleus, neuromuscular junction

  • Allow Na+ influx, leading to neuronal excitation

• Muscarinic receptors:

  • Metabotropic (G-protein coupled receptors)

  • Respond to muscarine (from Amanita muscaria mushroom); can be blocked by atropine

  • Located on effectors stimulated by cholinergic nerves (parasympathetic and some sympathetic)

Morphology and Structure of Nicotinic Receptors

• Composed of five subunits: α, β, γ, ε, δ

• Mediate fast excitatory responses in CNS and PNS

• Muscular and neuronal types differ in subunit composition

• Examples: Neuronal nicotinic α7, α4β2

Desensitization of Nicotinic Receptors

• Continuous agonist exposure leads to desensitization; receptors become unresponsive even when ligand is present.

Nicotine: Mechanism and Effects

• Acts as a nicotinic receptor agonist

• Chronic exposure causes up-regulation of nicotinic receptors in the prefrontal cortex

Muscarinic Receptors: Types and Signaling

• All muscarinic receptors are metabotropic and signal via G-proteins

• Five subtypes: M1–M5, each with distinct tissue distribution and function

• Operate through second messenger systems

Classification of Muscarinic Receptors

Receptor	Location	Main Function
M1	CNS, glands	Modulates cognitive function, glandular secretion
M2	Heart	Slows heart rate
M3	Smooth muscle, glands	Stimulates smooth muscle contraction, glandular secretion
M4	CNS	Modulates neurotransmission
M5	CNS	Modulates dopaminergic transmission

Genetic Deletion and Reward System

• Genetic deletion of the M5 muscarinic receptor reduces the rewarding effects of morphine.

• M5 is predominantly expressed in dopaminergic neurons of the ventral tegmental area (VTA) and substantia nigra, projecting to the nucleus accumbens (NAc) and prefrontal cortex.

• ACh binds to M5 receptors, activating the Gq protein and modulating dopamine transmission.

Additional info: The notes above expand on the original content by providing definitions, mechanisms, and clinical context for acetylcholine and its receptors, as well as the pharmacology of drugs affecting cholinergic transmission.